Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Bologna
Clinical trial register · Italy

Clinical Trials in Bologna, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 2846 Bologna 1303 Roma 1272 Naples 983 Rome 968
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna306 Istituto Ortopedico Rizzoli106 AstraZeneca45 Eli Lilly and Company30 Janssen Research & Development, LLC26
Site location
Milan2846 Bologna1303 Roma1272 Naples983 Rome968
All 489 locations
Target enrolment
to

Trials with a site in Bologna

1303 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Alexion Pharmaceuticals, Inc.
Phase 3
1,180
Bologna, Forlì, Florence, Rome, Messina, Naples, Padova, Pisa
2027-11-23
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
300
Bologna
2027-01-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
9
Bologna
2027-01-01
Recruiting
Reliability and Validation of the WB-MRI Radiological Score in CRMO
NCT07483853Chronic Recurrent Multifocal Osteomyelitis, Pediatrics
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
15
Bologna
2027-01-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
600
Bologna
2026-12-15
Not yet open
INfections in Patients Treated With CAR-T
NCT07713511Relapsed Multiple Myeloma, Refractory Multiple Myeloma, B-Cell Non-Hodgkin Lymphoma, Bloodstream Infections
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
290
Bologna
2026-11-01
Not yet open
Istituto Ortopedico Rizzoli
Not applicable
20
Bologna
2026-11
Not yet open
Medtronic MiniMed, Inc.
Not applicable
230
Bologna, Milan, Naples, Roma
2026-10-15
Not yet open
Cefepime/Enmetazobactam for Bacteremic Complicated Urinary Tract Infections
NCT07725848Complicated Urinary Tract Infections, Antibiotic Resistance
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Bologna, Catania, Milan
2026-10-15
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna
2026-10-02
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 3
168
Bologna, Pisa, Torino
2026-10-01
Not yet open
Fondazione EMN Italy Onlus
Observational
92
Bari, Bologna, Brescia, Castelfranco Veneto, Como, Milan, Novara, Pavia
2026-10
Not yet open
Fondazione Italiana Linfomi - ETS
Observational
1,000
Candiolo, Castelfranco Veneto, Alessandria, Aviano, Bari, Bergamo, Bologna, Brescia
2026-10
Recruiting
Takeda
Phase 3
324
Bologna, Cona, Meldola, Rome, Milan, Ancona, Catania, Florence
2026-09-10
Recruiting
Incyte Corporation
Phase 3
426
Bari, Bergamo, Bologna, Catania, Florence, Genova, Meldola, Milan
2026-09-08
Recruiting
Kyowa Kirin, Inc.
Phase 1
72
Candiolo, Bergamo, Bologna, Torino
2026-09-02
Not yet open
Gruppo Oncologico del Nord-Ovest
Phase 3
244
San Giovanni Rotondo, Tricase, Rozzano, Orbassano, Aviano, Bari, Bologna, Crema
2026-09-01
Not yet open
Impact of Culture of Perfusion Fluid on Donor-derived Infection Management and Outcome in Liver and Kidney Transplant
NCT07651137Liver Transplant Infection, Kidney Transplant Infection, Liver Transplant, Kidney Transplant
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,400
Bologna
2026-09-01
Recruiting
AstraZeneca
Phase 3
2,800
Bari, Bologna, Cosenza, Cremona, Genoa, Milan, Modena, Naples
2026-09-01
Not yet open
Istituto Ortopedico Rizzoli
Not applicable
46
Bologna
2026-09
Not yet open
BV-CHP Real-life and Biological Evidences in Patients With sALCL
NCT07467317Anaplastic Large Cell Lymphoma
Fondazione Italiana Linfomi - ETS
Observational
100
Avellino, Aviano, Bari, Bergamo, Bologna, Candiolo, Legnano, Milan
2026-09
Recruiting
MaioRegen Prime Study for the Treatment of Deep Osteochondral Lesion of the Knee
NCT07332182Osteochondral Lesions of the Knee Joint, Osteochondritis Dissecans (OCD), Early Osteoarthritis
Fin-Ceramica Faenza Spa
Not applicable
400
Bologna
2026-09
Not yet open
Istituto Ortopedico Rizzoli
Not applicable
80
Bologna
2026-09
Not yet open
Istituto Ortopedico Rizzoli
Not applicable
46
Bologna
2026-09
Not yet open
Stefano Zaffagnini
Not applicable
46
Bologna
2026-09
Not yet open
Stefano Zaffagnini
Observational
50
Bologna
2026-09
Not yet open
Azienda USL Reggio Emilia - IRCCS
Observational
210
Bari, Bologna, Ferrara, Meldola, Milan, Modena, Naples, Reggio Emilia
2026-08-30
Recruiting
A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
NCT07845487Ulcerative Colitis (UC), Severe Ulcerative Colitis, Moderate Ulcerative Colitis
DrugPALI-2108
Palisade Bio
Phase 2
204
Bari, Bologna, Matera, Negrar, Rome, Rozzano, San Giovanni Rotondo, Turin
2026-08-28
Not yet open
AstraZeneca
Phase 3
750
Bologna, Milan, Rome, Rozzano, Torino
2026-08-25
Recruiting
AstraZeneca
Phase 3
7,000
Alessandria, Bari, Bologna, Catania, Chieri, Cinisello Balsamo, Cosenza, Eboli
2026-08-21
Recruiting
AstraZeneca
Phase 3
2,500
Bologna, Milan, Palermo, Pisa, Roma, Rozzano, Sesto San Giovanni, Torino
2026-08-19
Recruiting
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
NCT07746895C3 Glomerulopathy (C3G), Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
DrugPegcetacoplan
Swedish Orphan Biovitrum
Phase 4
150
Bari, Bologna, Foggia, Messina, Milan, Roma, Udine
2026-08-05
Recruiting
VectivBio AG
Phase 3
124
Pavia, Padova, Bologna, Florence, Milan, Torino
2026-08
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
150
Bologna, Meldola, Mantua, Carpi, Modena, Sassuolo, Piacenza, Parma
2026-07-30
Recruiting
Stefano Zaffagnini
Observational
150
Bologna
2026-07-08
Recruiting
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
NCT07692490Liver Transplantation (LT), Ischemia-Reperfusion Injury, Early Allograft Dysfunction
The Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Not applicable
170
Ancona, Bari, Bergamo, Bologna, Genova, Modena, Padova, Palermo
2026-07-07
Recruiting
AstraZeneca
Phase 3
1,200
Bari, Bologna, Chieti, Milan, Modena, Naples, Roma
2026-07-06
Not yet open
University of Padova
Not applicable
105
Bologna, Padova, Roma
2026-07-01
Recruiting
Prilenia
Phase 3
400
Bologna, Milan, Naples, Padova, Roma, San Giovanni Rotondo
2026-07-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
70
Bologna
2026-06-30
Recruiting
AstraZeneca
Phase 3
4,500
Bologna, Catania, Chieti, Florence, Latina, Milan, Pisa, Ravenna
2026-06-29
Recruiting
AstraZeneca
Phase 3
750
Bologna, Milan, Rome, Rozzano, Torino
2026-06-26
Recruiting
A Study of ARC-02 in B-cell NHL
NCT07691606B-cell Non Hodgkin Lymphoma
DrugRituximab
Taiho Oncology, Inc.
Phase 1
140
Aviano, Bergamo, Bologna, Rozzano
2026-06-22
Recruiting
Chiesi Italia
Observational
75
Arezzo, Bari, Bologna, Caserta, Monza, Naples, Palermo
2026-06-15
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna
2026-06-12
Active, closed
AstraZeneca
Phase 2
326
Bologna, Florence, Milan, Padova, Pavia, Pisa, Torino, Torrette - Ancona
2026-06-11
Recruiting
Italian YOLO: A Web-Based ACT Mental Health Promotion Intervention for University Students
NCT07654569Psychological Distress, Psychological Wellbeing, Academic Stress
University of Bologna
Not applicable
1,000
Bologna
2026-06-10
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
146
Bologna
2026-06-08
Recruiting
Fondazione Italiana Linfomi - ETS
Phase 2
41
Alessandria, Bologna, Brescia, Florence, Genova, Milan, Palermo, Pescara
2026-06-05
Recruiting
Takeda
Phase 2
92
Bologna, Verona
2026-06-04
Recruiting
Bayer
Phase 3
117
Bergamo, Bologna, Genova, Milan, Naples, Padova, Roma, Torino
2026-06-01
Not yet open
Safety of Bronchoscopy in Patients With Interstitial Lung Disease
NCT07627594Interstitial Lung Disease (ILD), Bronchoscopy, Bronchoalveolar Lavage (BAL), Acute Exacerbation
University of Milan
Observational
427
Milan, Bologna, Genova, Legnano, Modena, Monza, Naples, Siena
2026-06-01
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
144
Bari, Bologna, Meldola, Foggia, Florence, Genova, Province of Macerata, Milan
2026-06
Not yet open
Azienda Usl di Bologna
Not applicable
60
Bologna
2026-06
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bari, Bologna, Bolzano, Milan, Novara, Palermo, Pescara, Rimini
2026-05-31
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
10,000
Bologna
2026-05-30
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
NCT07101328Lymphoma, Non-Hodgkin, B-cell Lymphoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular
Eli Lilly and Company
Phase 1
215
Bologna, Naples, Rozzano
2026-05-28
Recruiting
University Hospital of Ferrara
Not applicable
1,612
Andria, Arezzo, Bologna, Ferrara, Grosseto, L’Aquila, Mirano, Ravenna
2026-05-25
Recruiting
Novo Nordisk A/S
Phase 3
2,500
Bologna, Genoa, Brescia, Milan, Perugia, Messina, Ancorna, Pisa
2026-05-21
Recruiting
Takeda
Phase 3
300
Florence, Rozzano, Pavia, Roma, Candiolo, Bologna, Milan, Naples
2026-05-21
Recruiting
Incyte Corporation
Phase 2
60
Bologna, Genova, Monza, Padua, Pavia, Rome
2026-05-20
Not yet open
FMT for Pediatric SR-aGVHD
NCT07602751Acute Graft Versus Host Disease in Intestine
DrugFecal Microbial Transplantation
Bambino Gesù Hospital and Research Institute
Phase 1/2
20
Bologna, Padova, Roma
2026-05-18
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
78
Bologna
2026-05-13
Recruiting
Novartis Pharmaceuticals
Phase 3
5,700
Ancona, Bergamo, Bologna, Brescia, Cona, Florence, Pozzilli, Milan
2026-05-11
Recruiting
Novo Nordisk A/S
Phase 3
5,610
Chieti, Cosenza, Naples, Bentivoglio, Bologna, Ferrara, Reggio Emilia, Udine
2026-05-11
Recruiting
Incyte Corporation
Phase 1
218
Bologna, Milan, Roma, Udine
2026-05-11
Recruiting
Mirati Therapeutics Inc.
Phase 2
170
Orbassano, Rome, Florence, Bologna, Meldola, Milan, Pesaro, Roma
2026-05-06
Not yet open
U.G.A. Nutraceuticals
Not applicable
50
Bologna
2026-05-04
Active, closed
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
NCT07825207Myelodysplastic Neoplasm, Myelodysplastic Syndrome
DrugEltrombopag
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Observational
100
Alessandria, Bari, Bologna, Brescia, Candiolo, Florence, Genova, Mantua
2026-05-01
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
108
Bologna, Cuneo, Meldola, Cona, Lido di Camaiore, Lucca, Mantua, Pisa
2026-05
Not yet open
Azienda Usl di Bologna
Observational
5,200
Bologna
2026-05
Recruiting
Alkermes, Inc.
Phase 3
176
Bologna
2026-04-22
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
204
Bologna
2026-04-22
Recruiting
Janssen Research & Development, LLC
Phase 3
530
Bologna, Bolzano, Genova, Milan, Roma, Rozzano, Torino
2026-04-21
Active, closed
Novo Nordisk A/S
Phase 3
606
Ferrara, Genoa, Pavia, Palermo, Padova, Verona, Bologna, Rozzano (MI)
2026-04-21
Recruiting
Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
NCT07585890End-stage Liver Disease (ESLD), Acute Liver Failure, Liver Cirrhosis, Liver Transplantation
University Medical Center Groningen
Observational
10,000
Bari, Bergamo, Bologna, Milan, Pisa, Torino
2026-04-21
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
800
Bologna
2026-04-17
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
NCT07226843Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell, Follicular Lymphoma
DrugRituximab
Eli Lilly and Company
Phase 1
460
Bologna, Milan
2026-04-17
Recruiting
K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
Phase 3
420
Bologna, Milan, Naples, Prato, Rome
2026-04-17
Recruiting
Istituto Ortopedico Rizzoli
Observational
16
Bologna
2026-04-15
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Observational
100
Bari, Bergamo, Bologna, Misterbianco, Monza, Milan, Modena, Padova
2026-04-14
Recruiting
Novo Nordisk A/S
Phase 3
630
Bologna, Rome, Milan, Palermo
2026-04-13
Recruiting
Indena S.p.A
Not applicable
60
Bologna
2026-04-10
Recruiting
Incyte Corporation
Phase 3
588
Bologna, Brescia, Candiolo, Foggia, Milan, Naples, Pisa, Roma
2026-04-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
758
Meldola, Rozzano, Catselfranco Veneto, Florence, Bari, Bologna, Milan, Perugia
2026-04-09
Recruiting
Casa di Cura Dott. Pederzoli
Observational
200
Bologna, Padova, Roma, Trieste, Udine, Peschiera del Garda
2026-04
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
120
Bologna
2026-03-31
Recruiting
University of Turin, Italy
Not applicable
820
Rozzano, Bologna, Florence, Foggia, Genova, Milan, Modena, Naples
2026-03-30
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
150
Bologna
2026-03-26
Recruiting
Eisai Inc.
Phase 2
64
Bologna, Pavia, Verona
2026-03-26
Recruiting
Novartis Pharmaceuticals
Phase 3
770
Bologna, Brescia, Milan
2026-03-24
Recruiting
Stefano Zaffagnini
Observational
51
Bologna
2026-03-24
Recruiting
Merck Sharp & Dohme LLC
Phase 2
100
Bologna
2026-03-24
Recruiting
Boehringer Ingelheim
Phase 2
132
Ancona, Bari, Bologna, Messina, Milan, Pavia, San Giovanni Rotondo (FG), Verona
2026-03-23
Recruiting
Hoffmann-La Roche
Phase 3
1,600
Bergamo, Catanzaro, Bologna, Rome, Milan, Palermo, Perugia
2026-03-23
Recruiting
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
NCT07219459Unresectable or Metastatic Hepatocellular Carcinoma, Child-Pugh A Hepatocellular Carcinoma, Failure of First-Line Treatment That Included an Approved Anti PD-(L)1 Compound
DrugsVisugromab RDE·Opdivo·Lenvatinib·Nivolumab
CatalYm GmbH
Phase 2
104
Bologna, Milan, Ravenna
2026-03-19
Recruiting
Sustainable and Inclusive Use of Alternative Proteins in Mediterranean Supply Chains (CIPROMED)
NCT07553936Food Preferences, Satiety and Food Intake, Appetite Regulation, Overweight (BMI > 25)
University of Bologna
Not applicable
40
Bologna
2026-03-18
Recruiting
Assessment of Cardiac and Carotid Ultrasound Measurements in a Cohort of Healthy Children in Italy
NCT07666451Cardiovascular Imaging, Echocardiography, Carotid Intima-Media Thickness
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,400
Bologna
2026-03-17
Recruiting
Hoffmann-La Roche
Phase 3
2,000
Bergamo, Bari, Catanzaro, Bologna, Rome, San Donato Milanese (MI), Palermo, Pisa
2026-03-16
Recruiting
Sanofi
Phase 2/3
526
Torette, Milan, Rome, Bologna, Brescia, Novara
2026-03-13
Recruiting
Istituto Ortopedico Rizzoli
Observational
943
Bologna, Reggio Emilia
2026-03-09
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
600
Bologna
2026-03-04
Recruiting
Azienda Usl di Bologna
Not applicable
12
Bologna
2026-03-02
Recruiting
Renal and Hepatic Abnormal Doppler Patterns in Trauma
NCT07492511Trauma (Including Fractures), Trauma Patients, Kidney Disease, Hypovolemia
Azienda Usl di Bologna
Observational
350
Bologna
2026-03-01
Recruiting
Derivation and Validation of the Aortic Valve Echocardiographic Calcium Score to Confirm Severe Aortic Stenosis: the Echo-AVCS Study
NCT07620925Aortic Stenosis, Chronic Coronary Syndrome, Calcific Aortic Valve Disease, Calcific Aortic Stenosis
Azienda Ospedaliera "Sant'Andrea"
Observational
250
Bologna, Milan, Roma
2026-03-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
120
Bologna
2026-03
Recruiting
Istituto Ortopedico Rizzoli
Observational
30
Bologna
2026-02-28
Recruiting
Stefano Zaffagnini
Observational
300
Bologna
2026-02-25
Recruiting
argenx
Observational
100
Acquaviva delle Fonti, Ancona, Bari, Bergamo, Bologna, Catanzaro, Florence, Genova
2026-02-25
Recruiting
AstraZeneca
Phase 3
508
Bologna, Milan, Naples, Rozzano, Torino
2026-02-23
Recruiting
Boehringer Ingelheim
Phase 3
286
Bari, Bologna, Milan, Palermo, Pavia, Varese
2026-02-16
Recruiting
Bayer
Phase 4
50
Bergamo, Bologna, Florence, Lecce, Milan, Naples, Padova, Pavia
2026-02-13
Active, closed
Janssen Research & Development, LLC
Phase 2
168
Bergamo, Bologna, Cuneo, Florence, Palermo, Pavia, Pescara, Roma
2026-02-08
Recruiting
Stefano Zaffagnini
Not applicable
12
Bologna
2026-02-07
Recruiting
University of Bologna
Not applicable
40
Bologna
2026-02-02
Recruiting
Insights on Dissemination of Lung Cancer
NCT07476495Oncology & Epidemiology & Lung Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna
2026-02-01
Not yet open
Fondazione Italiana Linfomi - ETS
Phase 2
56
Meldola, Rozzano, Ancona, Avellino, Biella, Bologna, Brescia, Catania
2026-02-01
Recruiting
University of Bologna
Not applicable
40
Bologna
2026-02-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,260
Bologna
2026-02
Not yet open
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
270
Arezzo, Aviano, Bologna, Brescia, Catania, Cuneo, Florence, Genova
2026-01-31
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
20
Bologna
2026-01-30
Active, closed
A Trial of TAK-861 for the Treatment of Narcolepsy With Cataplexy
NCT07363720Narcolepsy Type 1 (NT1), Narcolepsy With Cataplexy
DrugTAK-861
Takeda
Phase 3
98
Bologna, Rome
2026-01-29
Recruiting
Upfront Targeted Axillary Dissection for Luminal Breast Cancer With Limited Axillary Involvement
NCT07278726ALND, Sentinel Lymph Node Biopsy (SLNB), Targeted Axillary Dissection (TAD)
European Institute of Oncology
Observational
150
Bologna, Forlì, Milan, Naples, Ortona, Pavia, Pisa, Roma
2026-01-28
Recruiting
BeOne Medicines
Phase 3
500
Bologna, Florence, Milan, Padova, Roma
2026-01-22
Recruiting
Sexual Well-being of Women Undergoing Mastectomy and Reconstruction
NCT07234461Mastectomy and Breast Reconstruction, Sexual Wellness
European Institute of Oncology
Not applicable
200
Bari, Bologna, Cesena, Forlì, Milan, Olbia, Padova, Palermo
2026-01-21
Recruiting
Vorasidenib Maintenance for IDH Mutant Astrocytoma
NCT06809322IDH-mutant Grade 2 or 3 Astrocytoma
DrugVorasidenib
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
468
Bologna, Padova, Roma, Torino
2026-01-16
Recruiting
A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
NCT07220616Hematological Malignancies, B-cell Non-Hodgkin Lymphoma
Daiichi Sankyo
Phase 1/2
420
Bologna
2026-01-16
Recruiting
Eli Lilly and Company
Phase 3
150
Ancona, Bologna, Cagliari, Florence, Milan, Naples, Novara, Padova
2026-01-12
Recruiting
AstraZeneca
Phase 1/2
84
Bologna, Ravenna
2026-01-09
Recruiting
Early Postoperative Pain Following a Limb Amputation
NCT07393139Amputation, Surgical, Pain Management, Rehabilitation
Istituto Ortopedico Rizzoli
Observational
150
Bologna
2026-01-09
Recruiting
Incyte Corporation
Phase 1
280
Bologna, Milan, Rome, Verona
2026-01-08
Recruiting
Insmed Incorporated
Phase 3
344
Bologna, Catania, Milan, Modena, Monza, Naples, Pavia, Roma
2026-01-07
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
800
Bologna
2026-01-07
Recruiting
Bristol-Myers Squibb
Phase 2/3
590
Naples, Ravenna, Aviano, Orbassano, Siena, Perugia, Bologna, Milan
2026-01-02
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Phase 2
15
Bologna
2026-01-01
Recruiting
NAIF 2.0 - COGNIFY
NCT07824297Dural Arteriovenous Fistula, Glymphatic System
Hospital Universitari Vall d'Hebron Research Institute
Observational
20
Bologna
2026-01-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
20
Bologna
2026-01
Recruiting
LEF1 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: A MARKER FOR DIAGNOSIS AND SURVIVAL PREDICTION
NCT07313982Chronic Lymphocytic Leukemia (CLL) / Small Lymphocytic Lymphoma (SLL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
350
Bologna
2025-12-31
Recruiting
PAX5-NEGATIVE HODGKIN-LIKE LYMPHOMAS: A DIAGNOSTIC CHALLANGE
NCT07313943Hodgkin or Non-Hodgkin Lymphoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna
2025-12-30
Recruiting
Incyte Corporation
Phase 2
56
Bologna, Brescia, Meldola, Milan, Naples, Padova, Roma
2025-12-29
Recruiting
Eli Lilly and Company
Phase 3
800
Bergamo, Bologna, Florence, Genova, Meldola, Milan, Misterbianco, Monza
2025-12-22
Active, closed
Taiho Oncology, Inc.
Phase 3
360
Alessandria, Ancona, Bergamo, Bologna, Catania, Meldola, Livorno, Legnano
2025-12-22
Recruiting
AEF0217 in Participants With Down Syndrome
NCT07334912Down Syndrome (Trisomy 21)
Aelis Farma
Phase 2
188
Bologna, Roma, Troina
2025-12-22
Recruiting
AstraZeneca
Observational
335
Salerno, Padova, Teramo, Treviso, Varese, Bari, Bergamo, Bologna
2025-12-20
Recruiting
European Myeloma Network B.V.
Phase 2
150
Ascoli Piceno, Bari, Bergamo, Bologna, Bolzano, Como, Milan, Novara
2025-12-12
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
288
Bologna
2025-12-11
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Bologna
2025-12-10
Recruiting
How Nocturnal Hypoventilation Predicts Long-term Response to Non-invasive Ventilation in Hypercapnic COPD Patients
NCT07414108COPD, COPD (Chronic Obstructive Pulmonary Disease), Hypercapnia, Hypercapnic Respiratory Failure, COPD
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
25
Bologna
2025-12-10
Recruiting
ALX Oncology Inc.
Phase 2
120
Torrette, Genova, Bergamo, Bologna, Milan, Monza, Novara
2025-12-10
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,200
Bologna, Cagliari, Catanzaro, Florence, Milan, Palermo, Potenza, Roma
2025-12-09
Recruiting
Incyte Corporation
Phase 3
466
Alba, Alessandria, Aviano, Bologna, Florence, Lecco, Milan, Mirano
2025-12-09
Recruiting
Voll Degradable Shoulder Spacer FIH Study
NCT07208448Massive Rotator Cuff Tear
Voll Medical Technologies Ltd.
Not applicable
20
Bergamo, Bologna
2025-12-09
Active, closed
Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine
NCT07727070Cirrhoses, Liver, Portal Hypertension Related to Cirrhosis, Liver Stiffness, Hepatic Encephalopathy
Fadoi Foundation, Italy
Observational
400
Ariccia, Arzignano, Assisi, Bologna, Bolzano, Brindisi, Casale Monferrato, Catanzaro
2025-12-05
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
1,260
Bari, Bologna, Catania, Ferrara, Milan, Novara, Palermo, Parma
2025-12-03
Recruiting
GlaxoSmithKline
Phase 3
450
Meldola, Rozzano MI, Bari, Bologna, Candiolo, Genova, Milan, Padova
2025-12-03
Recruiting
A ELN-Multicenter Study on Phenotypic Evolution and Clinical Outcomes
NCT07203768Polycythemia Vera, Thrombocythemia
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
678
Pavia, Vicenza, Alessandria, Bergamo, Bologna, Brescia, Florence, Milan
2025-12-01
Active, closed
Viral Infections of the Central Nervous System: Diagnosis and Clinical Outcome
NCT07358117Infection, Virus Disease, CNS Infection
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
4,000
Bologna
2025-12-01
Recruiting
Dompé Farmaceutici S.p.A
Phase 3
153
Bologna, Chieti, Florence, Roma, Verona
2025-12-01
Recruiting
Eli Lilly and Company
Phase 3
7,140
Bologna, Brescia, Ferrara, Florence, Genova, Milan, Monza, Palermo
2025-12-01
Recruiting
Genmab
Phase 3
660
Bologna, Meldola, Monza, Milan, Prato, Reggio Emilia
2025-11-28
Recruiting
Syndax Pharmaceuticals
Phase 3
468
Monza, Pesaro, Alessandria, Bergamo, Bologna, Brescia, Candiolo, Florence
2025-11-25
Not yet open
University of Padova
Observational
172
Bologna, Genova, Torino
2025-11-25
Recruiting
Hoffmann-La Roche
Phase 3
900
Naples, Salerno, Bologna, Cassino, Rome, Genoa, Brescia, Milan
2025-11-24
Recruiting
Azienda Usl di Bologna
Observational
240
Bologna
2025-11-24
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
260
Bologna
2025-11-21
Recruiting
Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
NCT07087054Carcinoid Syndrome, Carcinoid, Carcinoid Tumor, Carcinoid Tumor of Ileum
Crinetics Pharmaceuticals Inc.
Phase 3
141
Bologna, Milan, Rome, Turin
2025-11-19
Active, closed
Bayer
Phase 2
60
Bologna, Brescia, Genova, Roma
2025-11-19
Recruiting
Bayer
Phase 3
111
Bergamo, Bologna, Genova, Milan, Naples, Padova, Roma, Torino
2025-11-19
Recruiting
iOnctura
Phase 1/2
26
Florence, Rozzano, Bologna, Meldola, Udine
2025-11-17
Recruiting
Istituto Ortopedico Rizzoli
Observational
42
Bologna
2025-11-15
Recruiting
Oral Indicators for ED Screening
NCT07295197Eating Disorders, Oral Health, Eating Disorders Symptoms
University of Bologna
Observational
461
Bologna
2025-11-14
Recruiting
Incyte Corporation
Phase 3
250
Bologna, Brescia, Catania, Milan, Naples, Padua, Roma, Rome
2025-11-13
Active, closed
Novo Nordisk A/S
Phase 3
300
Rome, Palermo, Bologna, Milan
2025-11-05
By invitation
Istituto Ortopedico Rizzoli
Observational
26
Bologna
2025-11-04
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
NCT07085767Breast Cancer, Locally Advanced Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer
DrugsPalazestrant·Ribociclib·Letrozole
Olema Pharmaceuticals, Inc.
Phase 3
1,000
Naples, Bologna, Aviano, Rome, Genoa, Bergamo, Milan, Monza
2025-11-03
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
150
Bologna
2025-11-03
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
5,000
Bologna
2025-11-01
Recruiting
Daiichi Sankyo
Phase 3
686
Bologna, Candiolo, Fano, Genova, Livorno, Milan, Misterbianco, Orbassano
2025-10-24
Recruiting
Istituto Ortopedico Rizzoli
Observational
300
Bologna
2025-10-23
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
500
Bologna
2025-10-22
Recruiting
Eli Lilly and Company
Phase 3
1,630
Bologna, Catania, Lecce, Lucca, Milan, Modena, Naples, Prato
2025-10-22
Recruiting
Acesion Pharma
Phase 2
200
Bologna, Cona, Mestre, Milan, Modena
2025-10-22
Recruiting
A Non-interventional Study of Participants With BPDCN Treated With Chemotherapy
NCT07785180Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Stemline Therapeutics, Inc.
Observational
140
Alessandria, Bari, Bologna, Brescia, Catania, Florence, Milan, Naples
2025-10-17
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
90
Bologna
2025-10-15
Recruiting
Eli Lilly and Company
Phase 3
4,500
Bergamo, Bologna, Florence, Milan, Naples, Padova, Palermo, Roma
2025-10-15
Recruiting
Nurix Therapeutics, Inc.
Phase 2
100
Alessandria, Bologna, Milan, Ravenna
2025-10-15
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
520
Bologna
2025-10-15
Recruiting
Genentech, Inc.
Phase 1/2
285
Bologna, Meldola, Bergamo, Brescia, Milan
2025-10-07
Recruiting
Azienda Ospedaliero-Universitaria di Parma
Not applicable
310
Parma, Bologna, Cuneo, Milan, Udine
2025-10-07
Recruiting
Novo Nordisk A/S
Phase 3
1,280
Ancona - Torrette, Bologna, Bolzano, Brescia, Cona, Florence, Ivrea, Lecco
2025-10-02
Recruiting
Catholic University of the Sacred Heart
Not applicable
140
Bologna, Milan, Verona
2025-10-01
Recruiting
Janssen Research & Development, LLC
Phase 3
882
Bologna, Florence, Milan, Negrar-Verona, Roma, Rozzano, San Giovanni Rotondo
2025-10-01
Recruiting
Daiichi Sankyo
Phase 3
710
Bari, Bologna, Florence, Lecco, Milan, Torino
2025-09-30
Recruiting
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
200
Bologna, Catania, Milan, Padova, Roma, Salerno
2025-09-30
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
100
Bologna
2025-09-29
Recruiting
Kura Oncology, Inc.
Phase 3
1,300
Bologna, Ravenna, Trieste, Brescia, Ascoli Piceno, Perugia
2025-09-26
Recruiting
Jazz Pharmaceuticals
Phase 2
125
Milan, Bologna, Genoa, Misterbianco, Monza
2025-09-24
Recruiting
AstraZeneca
Phase 1/2
91
Bologna, Milan
2025-09-24
Recruiting
Bristol-Myers Squibb
Phase 3
3,040
L’Aquila, Cagliari, Rozzano, Baggiovara, Bologna, Chieti, Naples, Roma
2025-09-22
Recruiting
Laboratoires Thea
Observational
200
Bologna, Catania, Corigliano, Genova, Lecce, Lucca, Modena, Morrovalle
2025-09-19
Recruiting
SpringWorks Therapeutics, Inc., a healthcare company of Merck KGaA, Darmstadt, Germany
Phase 4
50
Meldola, Candiolo, Bologna, Milan, Naples, Roma
2025-09-17
Recruiting
A Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
NCT07091630Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, Chronic Inflammatory Demyelinating Polyradiculoneuropathy
DrugEmpasiprubart
argenx
Phase 3
160
Gussago, Trieste, Bologna, Genova, Milan, Pavia
2025-09-16
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
300
Bologna, Foggia
2025-09-15
Recruiting
Internal Jugular Vein Ultrasound for Volume Status Assessment in Haemodialysis
NCT07438613Haemodialysis, Volume Assessment, Point of Care Ultrasound (POCUS)
University of Bologna
Observational
100
Bologna
2025-09-15
Recruiting
Istituto Ortopedico Rizzoli
Observational
400
Bologna
2025-09-12
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
Naples, Bologna, Aviano, Genoa, Pontedera, Prato, Milan, Novara
2025-09-11
Recruiting
Azienda Usl di Bologna
Not applicable
22
Bologna
2025-09-11
Recruiting
Stefano Zaffagnini
Observational
43
Bologna
2025-09-10
Active, closed
Clear Cell Chondrosarcoma in Italy
NCT07360964Chondrosarcoma
Istituto Ortopedico Rizzoli
Not applicable
77
Bologna
2025-09-10
Recruiting
Emotional Allodynia Questionnaire (AEQ) in Fibromyalgia (PEARL)
NCT07677631Fibromyalgia, Chronic Pain, Nociplastic Pain
University of Bari
Observational
425
Bari, Bologna, Cagliari, Naples, Verona
2025-09-10
Recruiting
Bristol-Myers Squibb
Phase 2
182
Naples, Monza, Milan, Padova, Bologna
2025-09-09
Recruiting
BeOne Medicines
Phase 3
500
Bologna, Milan, Padova
2025-09-04
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Arzignano, Baggiovara, Bologna, Caserta, Ferrara, Ferrara (Cona), Florence, Genova
2025-09-02
Recruiting
NTC srl
Phase 3
412
Carpi, Aviano, Negrar, Bologna, Brescia, Como, Milan, Roma
2025-09-02
Recruiting
"Transarterial Microembolization (TAME) in Inflammatory Knee Pathology"
NCT07140367Inflammatory Articular Diseases, Knee Osteoarthristis
Istituto Ortopedico Rizzoli
Observational
43
Bologna
2025-09-01
Not yet open
Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
NCT07046663Cutaneous T-Cell Lymphoma/Mycosis Fungoides
Fondazione Italiana Linfomi - ETS
Observational
190
Ancona, Bergamo, Bologna, Brescia, Cagliari, Catania, Florence, Genova
2025-09
Recruiting
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
NCT06989359IgAN, C3G, Complement-mediated Kidney Disease, IgA Nephropathy (IgAN)
ADARx Pharmaceuticals, Inc.
Phase 2
45
Bergamo, Bologna, Pavia
2025-08-28
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
127
Bologna
2025-08-25
Recruiting
A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
NCT06920004Chronic Inflammatory Demyelinating Polyneuropathy, CIDP, CIDP - Chronic Inflammatory Demyelinating Polyneuropathy
DrugsEmpasiprubart·IVIG
argenx
Phase 3
218
Bologna, Pavia, Roma, Rozzano
2025-08-22
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
60
Bologna
2025-08-18
Recruiting
Takeda
Phase 3
150
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-08-14
Recruiting
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
NCT07096674Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugORX750
Centessa Pharmaceuticals (UK) Limited
Phase 2
90
Bologna, Verona
2025-08-12
Recruiting
AstraZeneca
Phase 3
250
Bologna, Brescia, Florence, Milan, Torino
2025-08-07
Recruiting
Sanofi
Phase 3
723
Florence, Genoa, Milan, Rome, Turin, Bologna, Messina, Novara
2025-08-06
Recruiting
Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During Pregnancy
NCT06113237Maternal Complications, Pregnancy Complication, Birth Outcomes, Adverse, Pregnancy
DrugCannabidiol
Jazz Pharmaceuticals
Observational
50
Bologna
2025-08-05
Recruiting
Pfizer
Phase 3
400
Bologna, Meldola, Naples, Milan
2025-08-05
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
227
Bologna, Milan, Roma, Torino
2025-08-05
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
156
Bologna
2025-08-04
Recruiting
AstraZeneca
Phase 3
800
Alessandria, Aviano, Bari, Bologna, Catania, Florence, Haifa, Milan
2025-08-01
Active, closed
Costantino Errani
Observational
60
Bologna
2025-08-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
21
Bologna
2025-08
Recruiting
Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis
NCT06967480Generalized Myasthenia Gravis, Anti-AChR Antibody Positive
DrugRavulizumab
Alexion Pharmaceuticals, Inc.
Observational
40
Bergamo, Bologna, Brescia, Florence, Imperia, Lecco, Messina, Milan
2025-07-31
Active, closed
Pfizer
Phase 3
208
Bologna, Brescia, Catania
2025-07-31
Recruiting
Harmony TPV EMEA PMS
NCT06906926Severe Pulmonary Valve Regurgitation
Medtronic Cardiovascular
Not applicable
80
Bologna, Padova
2025-07-30
Recruiting
Thyroid Carcinoma in Cancer Patients Undergoing Radiotherapy
NCT07473518Thyroid Carcinoma, Pediatric Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
2,550
Bologna
2025-07-30
Recruiting
Eli Lilly and Company
Phase 1/2
68
Bologna, Milan, Roma, Trieste
2025-07-30
Recruiting
Visible Abdominal Distension
NCT06369753Irritable Bowel Syndrome, Dyspepsia, Functional Bloating
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
100
Bologna
2025-07-30
Recruiting
Celgene
Phase 3
400
Bologna, Meldola, Rozzano, Pisa, Alessandria, Naples, Torino
2025-07-28
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Bologna
2025-07-23
Recruiting
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
NCT06943755Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
DrugsZanzalintinib·Everolimus
Exelixis
Phase 2/3
440
Aviano, Bologna, Meldola, Milan, Naples, Orbassano to, Palermo, Roma
2025-07-21
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
5
Bologna
2025-07-21
Recruiting
Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway
NCT07187947Gender Incongruence, Cardiovascular (CV) Risk, Cardiovascular Disease Risk Factor, Cardiovascular Disease Acute
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
500
Bologna
2025-07-18
Recruiting
Takeda
Phase 3
347
Bologna, Brescia, Genoa, Messina, Milan, Pavia, Piacenza, Torino
2025-07-15
Recruiting
A Standard Carbon Dioxide Flushing Protocol to Reduce Air Embolization During Thoracic Endovascular Aortic Repair
NCT07734584Type B Acute Aortic Syndrome, Thoracic and Thoracoabdominal Aneurysms With Crawford Extent I, II, III, or IV
University of Bologna
Not applicable
90
Bologna, Brescia, Genova, Padova
2025-07-15
Recruiting
Stefano Zaffagnini
Observational
164
Bologna
2025-07-13
Recruiting
Quovadis Associazione
Observational
120
Marcianise, Mercogliano, Sessa Aurunca, Bologna, Anzio, Milan, Cefalù, Ascoli Piceno
2025-07-10
Recruiting
Analysis of the Pathophysiological and Functional State of the Knee Joint
NCT06490770Osteoarthritis, Knee, Cartilage Degeneration
Istituto Ortopedico Rizzoli
Not applicable
25
Bologna
2025-07-09
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Ancona, Bologna, Brescia, Florence, Forlì, Lecce, Milan, Naples
2025-07-02
Recruiting
Istituto Ortopedico Rizzoli
Observational
20
Bologna
2025-07-01
Recruiting
Ipsen
Phase 2
132
Bologna, Milan, Pavia, Reggio Emilia
2025-06-30
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
600
Bologna
2025-06-30
Active, closed
Pfizer
Phase 1/2
74
Naples, Meldola, Aviano, Livorno, Bologna, Roma
2025-06-30
Recruiting
Eli Lilly and Company
Phase 3
290
Bologna, Castellana Grotte, Milan, Padova, Pisa, Rho, Roma, Rozzano
2025-06-26
Recruiting
Eli Lilly and Company
Phase 3
350
Bologna, Castellana Grotte, Milan, Padova, Pisa, Rho, Roma, Rozzano
2025-06-26
Active, closed
AbbVie
Phase 3
573
Monserrato, Rozzano, Milan, Naples, Rome, Bologna, Padova, Palermo
2025-06-17
Recruiting
Istituto Ortopedico Rizzoli
Observational
40
Bologna
2025-06-10
Recruiting
BioNTech SE
Phase 3
480
Bari, Bologna, Catania, Meldola, Milan, Naples, Roma, Torino
2025-06-10
Recruiting
SLIT ABS: Study on Patients With Autoimmune Podocytopathy
NCT07516964Nephrotic Syndrome With Edema (Diagnosis), Minimal Change Nephrotic Syndrome, Focal Segmental Glomerulosclerosis (FSGS), Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy
Meyer Children's Hospital IRCCS
Not applicable
50
Bagno a Ripoli, Florence, Bologna, Genova, Parma, Pisa, Prato, Reggio Emilia
2025-06-10
Recruiting
Boehringer Ingelheim
Phase 3
1,755
Ancona, Bologna, Catania, Genova, Messina, Milan, Monza (MB), Naples
2025-06-09
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bergamo, Bologna, Brescia, Meldola, Milan, Pavia, Perugia, Pesaro
2025-06-04
Recruiting
AstraZeneca
Phase 3
15,100
Altamura, Arzignano, Bergamo, Bologna, Brescia, Caserta, Catania, Cona
2025-06-04
Active, closed
Incyte Corporation
Phase 3
9
Alessandria, Ancona, Bergamo, Bologna, Brescia, Catania, Florence, Genova
2025-06-04
Active, closed
Istituto Ortopedico Rizzoli
Observational
382
Bologna
2025-06-03
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
100
Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Genova, Messina
2025-06-01
Recruiting
Myocardial Perfusion CMR for Differentiating and Characterizing Hypertrophic Cardiomyopathy Phenotypes
NCT07382128HCM - Hypertrophic Cardiomyopathy, Anderson Fabry Disease, Cardiac Magnetic Resonance Imaging, Amyloid Cardiomyopathy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
250
Bologna
2025-06-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
500
Bologna
2025-06-01
By invitation
Istituto Ortopedico Rizzoli
Observational
15
Bologna
2025-06-01
Recruiting
Readmission and Dehydration Prevention in Patients With Elective Ileostomy
NCT06824623Ileostomy - Stoma, Colorectal Surgery, Dehydration
Multidisciplinary Italian Study group for STOmas (MISSTO)
Observational
300
Legnano, Milan, Monza, Palermo, Rovigo, Sesto San Giovanni, Bologna
2025-06-01
Not yet open
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Orbassano, Bari, Bologna, Cagliari, Cuneo, Ferrara, Florence, Genova
2025-06-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna
2025-06
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Bologna
2025-05-30
Not yet open
University of Bologna
Observational
80
Bologna
2025-05-30
Recruiting
Safety and Efficacy of Crofelemer in Adult Patients With Short Bowel Syndrome and Intestinal Failure (SBS-IF) Without Colon-in-continuity (CIC)
NCT06904872Short Bowel Syndrome, Malabsorption Syndromes, Short Gut Syndrome, Post-Op Complication
DrugCrofelemer
Napo Therapeutics, S.p.A.
Phase 2
18
Bologna, Naples, Padova
2025-05-29
Recruiting
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
DrugsSPY001·SPY002·SPY003
Spyre Therapeutics, Inc.
Phase 2
645
Castellana Grotte, Pavia, Legnano, Rozzano, San Donato Milanese, Segrate, Turin, Bologna
2025-05-27
Recruiting
Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer
NCT05815927Oligometastatic Squamous Cell Carcinoma of the Head and Neck
DrugPembrolizumab
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
200
Bologna, Cuneo, Florence, Milan, Naples, Ravenna, Rome
2025-05-23
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Bergamo, Bologna, Brescia, Candiolo, Cremona, Florence, Meldola, Milan
2025-05-22
Active, closed
Alkermes, Inc.
Phase 2
126
Bologna, Milan, Verona
2025-05-22
Recruiting
Istituto Ortopedico Rizzoli
Observational
60
Bologna
2025-05-21
Recruiting
Eli Lilly and Company
Phase 4
279
Bologna, Milan
2025-05-20
Recruiting
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
NCT06876649Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
DrugPirtobrutinib
Eli Lilly and Company
Phase 4
787
Bologna, Milan
2025-05-20
Recruiting
SecuraBio
Phase 3
124
Alessandria, Bergamo, Bologna, Naples, Rome
2025-05-19
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 3
450
Bologna, Milan, Padova, Parma, Torino
2025-05-19
Recruiting
National Epidemiology of Cutaneous Lymphomas
NCT07463989Lymphoma With Cutaneous Involvement
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Bologna
2025-05-13
Recruiting
Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
NCT06563895Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis, Cardiomyopathies
DrugAcoramidis
Eidos Therapeutics, a BridgeBio company
Phase 3
587
Bologna, Florence, Pavia, Pisa, Roma, Rome
2025-05-12
Active, closed
Merck Sharp & Dohme LLC
Phase 2
130
Milan, Verona, Bologna, Genova, Pavia, Roma, Sassari
2025-05-12
Recruiting
Hoffmann-La Roche
Phase 3
425
Matera, Bologna, Rome, Brescia, Milan, San Donato Milanese (MI), Negrar
2025-05-12
Recruiting
AstraZeneca
Phase 3
1,220
Bologna, Milan, Palermo, Perugia, Pisa, Roma, Rozzano
2025-05-06
Recruiting
Takeda
Phase 2
88
Rome, Verona, Bologna
2025-05-06
Recruiting
Unmet Needs Among Patients With Isolated REM Sleep Behavior Disorder (iRBD) and Their Significant Others
NCT07498452REM Sleep Behavior Disorder, Isolated REM Sleep Behavior Disorder
Universita di Verona
Observational
150
Bologna, Genoa, Milan, Pavia, Cagliari, Troina, Pisa, Verona
2025-05-06
Recruiting
Stichting Hemato-Oncologie voor Volwassenen Nederland
Phase 3
448
Ancona, Bologna, Civitanova Marche, Milan, Pagani, Palermo, Perugia, Pescara
2025-05-05
Recruiting
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry
NCT06086132Cancer Related Cardiovascular Toxicity
University of Bologna
Observational
10,000
Bologna, Palermo
2025-05-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
160
Bologna
2025-05
Recruiting
FAldini Sport Total Joint Arthroplasty-Knee II
NCT06383936Knee Osteoarthritis
Istituto Ortopedico Rizzoli
Not applicable
20
Bologna
2025-04-26
Active, closed
Eli Lilly and Company
Phase 3
905
Bologna, Catanzaro, Florence, Milan, Naples, Padova, Roma, Torino
2025-04-25
Recruiting
Lung Ultrasound for Guiding Antibiotic Use in Pediatric Pneumonia
NCT06921993Pneumonia Childhood, Pneumonia, Lung Ultrasound, Antibiotic Stewardship
Meyer Children's Hospital IRCCS
Not applicable
659
Florence, Bergamo, Bologna, Brescia, Genova, Milan, Naples, Novara
2025-04-24
Recruiting
BioNTech SE
Phase 1/2
380
Bologna, Genova, Milan, Naples, Roma
2025-04-23
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
25
Bologna
2025-04-14
Recruiting
Mario Negri Institute for Pharmacological Research
Not applicable
48
Bologna
2025-04-12
Recruiting
Hoffmann-La Roche
Phase 3
450
Tricase (LE), Caserta, Naples, Bologna, Meldola, Modena, Rome, Bergamo
2025-04-09
Active, closed
Arrowhead Pharmaceuticals
Phase 3
710
Rozzano, Bologna, Brescia, Milan, Palermo, Roma
2025-04-09
Recruiting
Ovulation Induction With GnRH Analogue or Dual Trigger?
NCT07546136Oncological Disease, Fertility Preservation
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Bologna
2025-04-07
Active, closed
Racial Disparities in Acute Stroke
NCT06955442Ischemic Stroke
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Observational
4,500
Bologna, Crema, Frosinone, Genova, Lecce, Naples, Pavia, Pozzilli
2025-04-03
Recruiting
PSMA PET for Treatment Response evaLuation of systemIC Therapies in prostAte caNcer (PELICAN)
NCT07089550PSMA Positive Tumors or Tumor Tissues, Prostate Cancer Metastatic
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,300
Bologna, Cuneo, Genova, Messina
2025-04-02
Recruiting
FDG-PET/CT vs. CT for Monitoring Metastatic Breast Cancer
NCT06877949Metastatic Breast Cancer, Response Monitoring
Odense University Hospital
Not applicable
420
Bologna, Milan
2025-04-02
Recruiting
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
Not applicable
14
Bologna
2025-04-01
Not yet open
Buda Health Center
Observational
300
Bologna
2025-04-01
Recruiting
Sensitivity and Tests for Evaluation of Plantar Fasciopathy
NCT07567807Plantar Fasciitis, Chronic
Istituto Ortopedico Rizzoli
Not applicable
45
Bologna
2025-04-01
Recruiting
University of Kiel
Not applicable
42
Bologna
2025-03-31
Not yet open
Comparison Between HUGO RAS Robotic Platform and Da Vinci Robotic Platform
NCT06844513Prostate Cancer (Adenocarcinoma), Renal Cancer
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
800
Bologna
2025-03-31
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
428
Bologna, Milan
2025-03-28
Recruiting
Prescient Therapeutics, Ltd.
Phase 2
115
Bologna, Brescia, Milan
2025-03-28
Recruiting
Daiichi Sankyo
Phase 3
582
Bari, Bologna, Catania, Milan, Monza, Naples, Pisa, Ponderano
2025-03-19
Recruiting
Stefano Zaffagnini
Observational
59
Bologna
2025-03-19
Recruiting
Immunovant Sciences GmbH
Phase 2
162
Bergamo, Bologna, Brescia, Milan, Pavia, Pisa, Roma, Siena
2025-03-18
Active, closed
Amgen
Phase 3
1,105
Bologna, Chieti, Florence, Milan, Palermo
2025-03-17
Recruiting
Integrative Multi-omics Analysis to Predict Monoclonal Gammopathies Clinical Evolution
NCT07214324Monoclonal Gammopathy of Undetermined Significance (MGUS), Smoldering Multiple Myeloma (SMM), Multiple Myeloma (MM)
Azienda USL Reggio Emilia - IRCCS
Observational
60
Bologna, Catania, Palermo, Reggio Emilia
2025-03-17
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
400
Bologna
2025-03-17
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,000
Rome, Bologna, Genova, Milan, Novara, Padova, Roma
2025-03-16
Recruiting
Istituto Ortopedico Rizzoli
Observational
70
Bologna, Argenta
2025-03-12
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 3
440
Milan, Rozzano, Turin, Bologna, Genova, Udine
2025-03-12
Recruiting
Moleculin Biotech, Inc.
Phase 2/3
312
Bologna, Florence, Ravenna, Roma
2025-03-12
Recruiting
AstraZeneca
Phase 2
80
Bologna, Castelfranco Veneto, Florence, Milan, Naples, Pavia, Pisa, Roma
2025-03-12
Active, closed
Amgen
Phase 3
3,853
Bologna, Chieti, Florence, Milan, Palermo, Pisa, Roma
2025-03-12
Recruiting
Pfizer
Phase 3
723
Avezzano, Rome, Bologna, Florence, Milan, Pavia, Roma
2025-03-11
Active, closed
A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer
NCT06521567Melanoma, Hodgkin Lymphoma, High and Low Grade Glioma, Glioblastoma Multiforme (GBM)
DrugsCobolimab·Dostarlimab
GlaxoSmithKline
Phase 1/2
83
Bologna, Naples
2025-03-06
Recruiting
AbbVie
Phase 1/2
252
Meldola, Milan, Rome, Orbassano, Ancona, Bologna
2025-03-06
Recruiting
BeOne Medicines
Phase 3
300
Bologna, Lecce, Meldola, Trieste, Verona
2025-03-05
Active, closed
Istituto Ortopedico Rizzoli
Not applicable
300
Bologna
2025-03-05
Recruiting
AstraZeneca
Phase 3
5,000
Bassano del Grappa, Bologna, Desio, Foggia, Genoa, Modena, Naples, Novara
2025-03-03
Not yet open
Uterine Doppler As StillbirthPredictor
NCT06825481Intrauterine Fetal Death
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
4,863
Bologna
2025-03-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
122
Bologna
2025-03
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
12,000
Bologna
2025-03
Not yet open
Consorzio Oncotech
Observational
1,000
Avellino, Bergamo, Bologna, Brescia, Termoli, Caserta, Cuneo, Ferrara
2025-03
Recruiting
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
NCT06517875Primary Myelofibrosis, Myelofibrosis; Primary Myelofibrosis; Post-polycythemia Vera Myelofibrosis; Post-essential Thrombocythemia Myelofibrosis
DrugsMomelotinib·Reblozyl·Luspatercept
GlaxoSmithKline
Phase 2
68
Bologna, Catania, Florence, Meldola FC, Milan, Roma
2025-02-28
Recruiting
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS
Observational
400
Ancona, Bari, Bologna, Brescia, Cagliari, Catania, Florence, Genova
2025-02-27
Recruiting
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Phase 3
339
Bologna, Genova, Palermo, Pescara, Perugia, Ravenna, Roma, Torino
2025-02-27
Recruiting
Takeda
Phase 3
171
Naples, Rome, Catania, Bologna, Milan, Monza, Novara, Torino
2025-02-27
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Alessandria, Bari, Bologna, Florence, Genova, Messina, Milan, Modena
2025-02-26
Recruiting
Bristol-Myers Squibb
Phase 3
530
Naples, Milan, Rome, Perugia, Peschiera del Garda, Bologna
2025-02-25
Active, closed
Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY
NCT05485831Lennox Gastaut Syndrome, Dravet Syndrome, Tuberous Sclerosis Complex
DrugCannabidiol
Jazz Pharmaceuticals
Observational
111
Bologna, Catanzaro, Chieti, Florence, Genova, Messina, Milan, Naples
2025-02-24
Active, closed
Post Market Registry for GORE® TAG® Thoracic Branch Endoprosthesis
NCT06507865Aneurysm, Dissection, Aortic, TAA Thoracoabdominal Aortic Aneurysm, Thoracic Aortic Aneurysm
W.L.Gore & Associates
Observational
155
Bologna, Brescia, Cagliari, Genova, Padova
2025-02-20
Recruiting
Menarini Group
Phase 2
44
Bari, Bologna, Genoa, Parma, Rome, Torino
2025-02-18
Recruiting
Advancing Knowledge in Ischemic Stroke Patients on Oral Anticoagulants
NCT06823466Ischemic Stroke, Oral Anticoagulation, Atrial Fibrillation (AF), Outcome Assessment
University of L'Aquila
Observational
200
Ancona, Bari, Bologna, Città di Castello, Ferrara, Florence, Frosinone, L’Aquila
2025-02-12
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna, Bari, Cagliari, Catania, Catanzaro, Florence, Genova, Messina
2025-02-12
Active, closed
Sanofi
Phase 3
231
Cona, Florence, Genoa, Milan, Padua, Rome, Bologna
2025-02-12
Recruiting
Dianthus Therapeutics
Phase 3
256
Bergamo, Bologna, Genova, Gussago, Milan, Modena, Monza, Pavia
2025-02-10
Recruiting
Takeda
Phase 2
96
Pozzilli, Rome, Verona, Bologna
2025-02-07
Recruiting
LEOPARD Training and Validation Data Collection Study
NCT06675604Decompensated Liver Cirrhosis, Primary Biliary Cholangitis, Primary Sclerosing Cholangitis, Hepato-cellular Carcinoma
Assistance Publique - Hôpitaux de Paris
Observational
4,500
Ancona, Bari, Bologna, Genova, Milan, Modena, Naples, Padova
2025-02-04
Recruiting
Airway Therapeutics, Inc.
Phase 2/3
366
Bologna, Genova, Milan, Naples, Padova
2025-02-03
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
244
Bologna
2025-02-03
Recruiting
NovoCure GmbH
Phase 3
741
Torino, Bologna, Milan, Naples, Padova, Rozzano, Siena
2025-02-03
Not yet open
Study of Viral Respiratory Infections
NCT06764381Respiratory Infections
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
20,000
Bologna
2025-02-03
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
198
Bologna
2025-02
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
300
Bologna, Siena
2025-02
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna
2025-02
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
100
Bologna
2025-02
Recruiting
Night-shift Work and Breast Cancer
NCT06786949Breast Cancer Risk Factors
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
6,000
Bologna, Messina
2025-01-31
Recruiting
Clinical and Functional Assessment of Patients With Transfemoral Amputation Treated With Osteointegrated Implant
NCT06737770Prosthesis, Lower Limb Amputation Knee, Amputation; Traumatic, Leg, Lower
Istituto Ortopedico Rizzoli
Not applicable
15
Bologna
2025-01-31
Not yet open
Use of Machine-learning Algorithms, Biomarkers and Measures of Quality of Life to Personalize Medical Management of Liver and Heart Transplant Recipients
NCT06774768Artificial Intelligence (AI), Hepatocellular Carcinoma (HCC), Heart Transplantation, Liver Transplantation
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Bologna
2025-01-30
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies
NCT06564038Chronic Lymphocytic Leukaemia, Small Lymphocytic Lymphoma, Mantle-cell Lymphoma, Large B-cell Lymphoma
DrugsSurovatamig·Acalabrutinib·Vincristine·Doxorubicin
AstraZeneca
Phase 1/2
408
Bologna, Milan
2025-01-30
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
50
Bologna
2025-01-30
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Bologna, Cagliari, Florence, Milan, Naples, Padova, Palermo, Pavia
2025-01-28
Active, closed
AbbVie
Phase 1
4
Milan, Bologna, Perugia
2025-01-27
Recruiting
A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia
NCT06767683Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugALKS 2680
Alkermes, Inc.
Phase 2/3
786
Bologna, Milan, Verona
2025-01-27
Recruiting
Gruppo Oncologico Italiano di Ricerca Clinica
Phase 2
142
Aviano (PN), Bari, Bologna, Carpi, Cremona, Cuneo, Florence, Lido di Camaiore
2025-01-24
Not yet open
IRCCS San Raffaele
Observational
50
Bologna, Milan, Naples
2025-01-20
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
10
Bologna
2025-01-17
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
96
Bologna
2025-01-15
Active, closed
Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)
NCT06700343Relapsing-remitting Multiple Sclerosis (RRMS)
DrugOcrelizumab
Amgen
Phase 3
152
Bologna, Milan, Naples, Rome
2025-01-13
Recruiting
Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases
NCT06529913Allergic Contact Dermatitis, Metal Allergy, Food Allergy, Nickel Sensitivity
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not applicable
280
Bologna, Roma
2025-01-13
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
5
Bologna
2025-01-11
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
400
Bergamo, Bologna, Genova, Milan, Padova, Palermo, Pavia, Roma
2025-01-10
Not yet open
ESI
Not applicable
60
Bologna
2025-01-10
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
80
Bologna
2025-01-08
Recruiting
BioNTech SE
Phase 2/3
1,580
Avellino, Aviano, Bologna, Candiolo, Catania, Cona, Cremona, Lucca
2025-01-07
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
120
Bologna
2025-01-07
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna
2025-01-07
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
275
Bologna
2025-01-07
Active, closed
Pfizer
Phase 3
1,035
Bologna, Meldola(FC), Rome, Florence, Milan, Novara, Padova, Roma
2025-01-06
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Bologna
2025-01-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
10,000
Bologna
2025-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
45
Bologna
2025-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
150
Bologna
2025-01
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
86
Bologna, Roma
2025-01
Recruiting
A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
NCT06752668Narcolepsy Type 1, Narcolepsy Type 2, Idiopathic Hypersomnia
DrugORX750
Centessa Pharmaceuticals (UK) Limited
Phase 2
248
Bologna, Pozzilli, Verona
2024-12-23
Recruiting
Istituto Oncologico Veneto IRCCS
Not applicable
200
Bergamo, Bologna, Foggia, Padova, Palermo, Udine, Verona
2024-12-20
Recruiting
Immunovant Sciences GmbH
Phase 2
240
Bologna, Cagliari, Genova, Milan, Naples, Pisa, Roma, Siena
2024-12-17
Recruiting
Study on Disease Characteristics and Treatment in Locally Advanced or Recurrent / Metastatic Cervical Cancer in Italy
NCT06771193Cervical Cancer, Locally Advanced Cervical Cancer, Recurrent Cervical Cancer, Metastatic Cervical Cancer
MSD Italia S.r.l.
Observational
200
Bologna, Catania, Genova, Milan, Modena, Naples, Aviano, Roma
2024-12-17
Recruiting
IBSA Farmaceutici Italia Srl
Not applicable
99
Bologna
2024-12-17
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
90
Bologna
2024-12-16
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
135
Bologna
2024-12-15
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Bologna, Cremona, Florence, Milan, Modena, Padova, Piacenza, Roma
2024-12-13
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
212
Alessandria, Ancona, Ascoli Piceno, Bari, Biella, Bologna, Bolzano, Ferrara
2024-12-13
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Palermo, Siena, Bologna
2024-12-12
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
700
Bologna
2024-12-11
Active, closed
BIOmarker Based Diagnostic TOOLkit to Personalize Pharmacological Approaches in Congestive Heart Failure
NCT07470554Heart Failure With Reduced Ejection Fraction (HFrEF), Congestive Heart Failure(CHF)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
4,254
Bologna
2024-12-10
Active, closed
Kumquat Biosciences Inc.
Phase 1
13
Bologna, Rome, Milan
2024-12-09
Recruiting
Azienda Usl di Bologna
Not applicable
304
Bologna
2024-12-09
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
59
Alessandria, Bologna, Catania, Cosenza, Ferrara, Meldola, Milan, Padova
2024-12-09
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Bologna
2024-12-05
Active, closed
PPM Services S.A.
Phase 3
400
Ancona, Florence, Genova, Parma, Pavia, Roma, Bologna, Catania
2024-12-05
Active, closed
AstraZeneca
Phase 3
181
Bologna, Catania, Florence, Padua, Pisa, Roma, Rozzano
2024-12-03
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Ancona, Bologna, Florence, Milan, Pavia, Roma, Torino
2024-12-03
By invitation
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
NCT06679946Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
DrugVutrisiran
Alnylam Pharmaceuticals
Phase 3
700
Bologna, Florence, Pavia
2024-12-03
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
350
Bologna
2024-12-03
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
1,400
Bologna
2024-12-03
Active, closed
H. Lundbeck A/S
Phase 3
401
Bologna, Milan, Naples, Pisa, Salerno
2024-12-03
Recruiting
Novo Nordisk A/S
Phase 2
465
L’Aquila, Chieti, Bologna, Bergamo, Brescia, Milan, Pisa, Roma
2024-12-02
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Bologna, Genova, Milan, Pisa
2024-12-02
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
80
Bologna
2024-12-01
Recruiting
University of Bologna
Not applicable
230
Bologna
2024-12-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
40
Bologna
2024-12-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
160
Bologna, Verona
2024-12
Not yet open
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
125
Bologna
2024-12
Recruiting
Cardiometabolic Risk of Obese Subjects: Cross-sectional Study
NCT06714058Obesity and Obesity-related Medical Conditions, Cardiovascular Risk, Genetics
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
240
Bologna, Catanzaro
2024-11-30
Active, closed
Martina Stefanini
Not applicable
10
Bologna
2024-11-27
Recruiting
Surovatamig (AZD0486) as Monotherapy in Participants With Relapsed/Refractory (R/R) B-cell NHL
NCT06526793B-cell Non-Hodgkin Lymphoma, Follicular Lymphoma (FL), Large B-Cell Lymphoma (LBCL)
DrugSurovatamig
AstraZeneca
Phase 2
270
Alessandria, Bologna, Busto Arsizio, Milan, Roma
2024-11-27
Recruiting
BeOne Medicines
Phase 1/2
80
Bologna, Milan, Naples, Rozzano, Verona
2024-11-27
Recruiting
Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
NCT07401615Non Small Cell Lung Cancer, Pulmonary Stereotactic Radiotherapy
Istituto Clinico Humanitas
Observational
150
Bergamo, Bologna, Catania, Milan, Rozzano, Naples, Roma, Venezia
2024-11-25
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
46
Lagosanto, Bologna
2024-11-22
Recruiting
Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH
NCT06813508Metabolic Dysfunction-Associated Steatotic Liver Disease, Hepatocellular Carcinoma, Metabolic Dysfunction-Associated Steatohepatitis, Liver Transplant
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,000
Bologna
2024-11-20
Recruiting
Role of Spectral CT in the Diagnosis of Myocarditis/MINOCA in Patients Undergoing cardioCT Investigations for Acute Chest Pain
NCT06804278Cardiac Imaging Techniques, Cardiac Imaging, Myocardial Disease, Myocarditis Acute
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Bologna
2024-11-18
Active, closed
A Phase 2 Trial of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)
NCT06422884Idiopathic Pulmonary Fibrosis, Progressive Fibrosing Interstitial Lung Disease
DrugTaladegib
Endeavor Biomedicines, Inc.
Phase 2
213
Bologna, Padova, Florence, Catania, Milan, Turin
2024-11-15
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
30
Bologna
2024-11-13
Recruiting
Boehringer Ingelheim
Phase 3
1,590
Bologna, Foggia, Milan, Modena, Palermo, Rome, Rozzano, Torino
2024-11-12
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
234
Bologna
2024-11-08
Active, closed
Amgen
Phase 2
409
Bari, Bologna, Chieti, Milan
2024-11-07
Recruiting
CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation
NCT06774365Heart Transplantation, Rejection Heart Transplant, HLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
683
Bari, Bologna, Milan, Naples
2024-11-07
Active, closed
Istituto Ortopedico Rizzoli
Observational
42
Bologna
2024-11-05
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
600
Alessandria, Bari, Bologna, Brescia, Cagliari, Ferrara, Florence, Foggia
2024-11-04
Recruiting
argenx
Observational
680
Bergamo, Bologna, Naples, Pisa, Roma
2024-11-04
Recruiting
F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
Observational
300
Bari, Bologna, Cagliari, Ferrara, Florence, Foggia, Genova, Messina
2024-11-04
Recruiting
Gruppo Italiano Malattie EMatologiche dell'Adulto
Observational
100
Ancona, Bergamo, Bologna, Brescia, Candiolo, Florence, Milan, Naples
2024-11-01
Recruiting
Istituto Ortopedico Rizzoli
Observational
200
Bologna
2024-11-01
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
236
Bologna
2024-11-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
1,293
Bologna
2024-11-01
Recruiting
Intraoperatory Hemodynamic Monitoring in OLT
NCT06703008Liver Transplantation
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
180
Bologna
2024-11-01
Recruiting
Istituto Ortopedico Rizzoli
Observational
1,000
Bologna, Genova, Milan, Pavia, Roma, Rozzano
2024-10-31
Recruiting
Advanced Surgical Simulation Processes in the Correction of Skeletal Defects and Deformities
NCT06380530Musculoskeletal Deformity, Musculoskeletal Abnormalities, Musculoskeletal Disorder
Istituto Ortopedico Rizzoli
Not applicable
100
Bologna, Rozzano, Genova, Milan, Pavia, Roma
2024-10-31
Recruiting
Abivax S.A.
Phase 2
212
Bologna, Catanzaro, Milan, Negrar, Pavia, Roma, Rozzano, San Giovanni Rotondo
2024-10-30
Active, closed
Fondazione Italiana Linfomi - ETS
Observational
241
Milan, Aviano, Bergamo, Bologna, Brescia, Cagliari, Cuneo, Florence
2024-10-30
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
200
Meldola, Bologna, Cagliari, Naples
2024-10-30
Recruiting
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
NCT06663332Crohns Disease, Colitis, Ulcerative, Arthritis, Psoriatic, Arthritis, Juvenile
DrugGuselkumab
Janssen Research & Development, LLC
Phase 3
196
Bergamo, Bologna, Roma, San Giovanni Rotondo, Trieste
2024-10-29
Recruiting
Istituto Ortopedico Rizzoli
Observational
397
Bologna
2024-10-24
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
100
Bologna
2024-10-23
Active, closed
Fondazione Italiana Linfomi - ETS
Phase 2
56
Candiolo, Alessandria, Ancona, Bologna, Brescia, Catania, Florence, Milan
2024-10-23
Recruiting
Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel Syndrome
NCT06681012Irritable Bowel Syndrome (IBS), Irritable Bowel Syndrome of Diarrhea Type (IBS-D)
Devintec Sagl
Not applicable
330
Bologna, Milan, Naples, Padova, Pavia, Pisa, Roma
2024-10-22
Recruiting
Italian Group of Regenerative and Occlusive Worldwide-used Techniques of Hepatic Hypertrophy
NCT07445412Liver Tumours, Liver Cancer (Primary and Metastatic), Liver Resection, Liver Hypertrophy
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
2,000
Bologna
2024-10-22
Recruiting
Familial Intrahepatic Cholestasis-related Genes Associated with Disease Susceptibility in Hepato-biliary Cancers
NCT06777914Hepatobiliary Cancers, Progressive Familial Intrahepatic Cholestasis (PFIC), Cholestatic Liver Disease
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
600
Bologna
2024-10-22
Recruiting
Istituto Ortopedico Rizzoli
Observational
59
Bologna
2024-10-18
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
40
Bologna
2024-10-17
Recruiting
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
Observational
617
Alessandria, Bergamo, Bologna, Catania, Florence, Milan, Monza, Naples
2024-10-14
Recruiting
Boehringer Ingelheim
Phase 3
1,800
Bologna, Foggia, Milan, Modena, Novara, Palermo, Rome, Rozzano
2024-10-14
By invitation
PET-TC in Thyroid Evaluation
NCT06852144Medullary Thyroid Carcinoma, Hyperparathyroidism, Parathyroid Carcinoma
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
418
Bologna
2024-10-14
Recruiting
Catholic University of the Sacred Heart
Not applicable
50
Bologna, Roma
2024-10-14
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
200
Bologna
2024-10-11
Recruiting
North Eastern German Society of Gynaecological Oncology
Phase 2
640
Bologna, Brescia, Lecco, Milan, Monserrato, Padova, Pisa, Reggio Emilia
2024-10-11
Active, closed
Incyte Corporation
Phase 2
130
Bergamo, Bologna, Milan, Rome, Rozzano, Torino
2024-10-11
Recruiting
Variation in Drug Interactions in People With HIV (PLWH) Aged 60 Years and Older.
NCT06717581HIV Infections, Drug Interaction, Elderly Infection, Comorbidities and Coexisting Conditions
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Bologna
2024-10-11
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
250
Bologna
2024-10-10
Active, closed
Eli Lilly and Company
Phase 2
143
Bologna, Brescia, Fano, Florence, Gazzi - Messina, Milan, Modena, Monserrato
2024-10-10
Active, closed
SynOx Therapeutics Limited
Phase 3
128
Rome, Candiolo, Palermo, Bologna, Milan
2024-10-09
By invitation
UCB Biopharma SRL
Phase 3
12
Bologna, Milan, Naples
2024-10-08
Recruiting
Efficacy of INM004 in Children With STEC-HUS
NCT06389474Hemolytic-Uremic Syndrome
Inmunova S.A.
Phase 3
220
Bari, Bologna, Genova, Milan, Padova
2024-10-05
Recruiting
Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and Company
Phase 1
256
Bologna, Milan
2024-10-03
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Bologna, Catania, Milan, Padova, Roma, Salerno
2024-10-02
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
30
Bologna
2024-10-01
Active, closed
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
30
Bologna
2024-10-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
360
Bologna
2024-10-01
Recruiting
Istituto Ortopedico Rizzoli
Observational
15
Bologna
2024-10-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
152
Bologna
2024-10-01
Recruiting
University Hospital, Geneva
Not applicable
220
Bologna
2024-10-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna
2024-10-01
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
50
Bologna
2024-09-30
Recruiting
Diagnosis and Treatment of Late Neurological Ischemic Deficit in Patients Suffering From Subarachnoid Hemorrhage.
NCT06804421Aneurysmal Subarachnoid Haemorrhage, Delayed Ischemic Neurological Deficit
Fondazione IRCCS San Gerardo dei Tintori
Observational
1,400
Bergamo, Bologna, Brescia, San Fermo della Battaglia, Cremona, Florence, Genova, Lecco
2024-09-28
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
San Giovanni Rotondo, Monserrato, Viagrande, Bologna, Meldola, Monza, Frattamaggiore, Aviano
2024-09-27
Recruiting
GlaxoSmithKline
Phase 2
393
Bergamo, Bologna, Messina, Milan, Padova, Roma
2024-09-27
Recruiting
Evaluation of Clinical and Radiological Outcomes in Patients Undergoing Fixation of Osteochondral Fragments With Reasorbable Screws in the Knee Joint
NCT06462040Osteochondral Defect, Osteochondritis Dissecans, Osteochondral Fracture, Osteochondral Fracture of Patella
Istituto Ortopedico Rizzoli
Observational
100
Bologna
2024-09-25
Recruiting
Istituto Oncologico Veneto IRCCS
Phase 2
104
Meldola, Messina, Bagno a Ripoli, Aviano, Rozzano, Bari, Bologna, Florence
2024-09-23
Recruiting
Costantino Errani
Observational
250
Bologna
2024-09-23
Recruiting
Development of Innovative Preclinical Ex Vivo Models for the Study of Sarcomas and Metastases From Solid Tumors
NCT07112989Bone and Soft Tissue Tumors, Bone Metastases From Solid Tumors, Lung Metastases
Istituto Ortopedico Rizzoli
Observational
125
Bologna
2024-09-23
Active, closed
argenx
Phase 3
141
Bergamo, Bologna, Milan, Naples, Roma
2024-09-18
Recruiting
AstraZeneca
Phase 1/2
174
Bologna, Milan
2024-09-18
Recruiting
Biomolecular Markers of Bone Metastasis
NCT06806462Bone Metastasis
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Not applicable
160
Bologna
2024-09-17
Recruiting
European Registry of Next Generation Imaging in Advanced Prostate Cancer
NCT06866782Prostate Cancer, Advanced Prostate Cancer, Metastatic Prostate Cancer (mPC)
Fundacio Puigvert
Observational
600
Bologna, Florence, Milan
2024-09-17
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna
2024-09-15
Recruiting
Consorzio Oncotech
Observational
300
Bari, Bologna, Cuneo, Catania, Meldola, Florence, Genova, Monza
2024-09-13
Recruiting
A Phase II Study of Ensifentrine in Non-Cystic Fibrosis Bronchiectasis
NCT06559150Non-cystic Fibrosis Bronchiectasis
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA
Phase 2
284
Bologna, Monza, Rozzano, Pavia, Catania
2024-09-11
Active, closed
Evaluation of the Effect of Lomitapide Treatment on Major Adverse Cardiovascular Events (MACE) in Patients With Homozygous Familial Hypercholesterolemia
NCT06832371Homozygous Familial Hypercholesterolemia (HoFH), Major Adverse Cardiovascular Events (MACE), Dyslipidemia
Fondazione SISA (Societa Italiana per lo Studio della Arteriosclerosi)
Observational
73
Catanzaro, Caserta, Naples, Bologna, Ferrara, Modena, Genova, Catania
2024-09-09
Recruiting
Prevention ICONA Dedicated Ensemble
NCT07186244PrEP, PrEP Adherence Monitoring, HIV, HIV -1 Infection
Fondazione ICONA
Observational
5,000
Chieti, Pescara, Bari, Foggia, Potenza, Caserta, Naples, Bologna
2024-09-09
Recruiting
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
NCT06528314NASH - Nonalcoholic Steatohepatitis, MASH - Metabolic Dysfunction-Associated Steatohepatitis
DrugEfruxifermin
Akero Therapeutics, Inc
Phase 3
2,150
Foggia, San Giovanni Rotondo, Rozzano, Torino, Bologna, Catania, Messina, Milan
2024-09-04
Recruiting
Gossamer Bio USA, Inc.
Phase 3
330
Bologna, Naples, Pavia, Roma
2024-09-03
Recruiting
Istituto Ortopedico Rizzoli
Not applicable
200
Bologna, Naples
2024-09-01
Recruiting
Study of Extracellular Vesicles (EV) in Patients Undergoing CAR-T Cell Therapies
NCT06554951CAR-T Cell Therapy, Extracellular Vesicles
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
100
Bologna
2024-08-31
Active, closed
Boehringer Ingelheim
Phase 3
11,000
Alessandria, Asti, Bari, Bergamo, Bologna, Cagliari, Chieri, Chieti
2024-08-30
Recruiting
Istituto Ortopedico Rizzoli
Observational
30
Bologna, Meldola
2024-08-30
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
60
Bologna
2024-08-30
Active, closed
Celgene
Phase 2
95
Rome, Rozzano, Bologna, Naples
2024-08-30
Recruiting
Bayer
Phase 3
555
Avellino, Aviano, Bologna, Florence, Lecce, Meldola, Milan, Orbassano
2024-08-28
Recruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Observational
65
Bologna
2024-08-28
Rows per page Showing 1–500 of 1303
1 2 3 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/bologna

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 1,303 of those studies with a site in Bologna.

How many clinical trials are recruiting in Bologna?

808 of the 1,303 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 63 have not yet opened recruitment, 418 are active but closed to new participants, and 14 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Bologna), 1,303 studies
PhaseStudiesRecruitingShare
Observational48937737.5%
Phase 336416027.9%
Not applicable18513214.2%
Phase 21446611.1%
Phase 1/251313.9%
Phase 2/333202.5%
Phase 126132%
Phase 41190.8%

Most active sponsors

Lead sponsors with the most studies (Bologna)
Lead sponsorStudiesRecruiting
IRCCS Azienda Ospedaliero-Universitaria di Bologna306241
Istituto Ortopedico Rizzoli10690
AstraZeneca4523
Eli Lilly and Company3017
Janssen Research & Development, LLC268
AbbVie254
Hoffmann-La Roche216
Novartis Pharmaceuticals207
University of Bologna2014
Merck Sharp & Dohme LLC1910
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.